Cardiac magnetic resonance imaging parameters as surrogate endpoints in clinical trials of acute myocardial infarction

Steffen Desch*, Ingo Eitel, Suzanne de Waha, Georg Fuernau, Philipp Lurz, Matthias Gutberlet, Gerhard Schuler, Holger Thiele

*Corresponding author for this work
32 Citations (Scopus)

Abstract

Cardiac magnetic resonance (CMR) offers a variety of parameters potentially suited as surrogate endpoints in clinical trials of acute myocardial infarction such as infarct size, myocardial salvage, microvascular obstruction or left ventricular volumes and ejection fraction. The present article reviews each of these parameters with regard to the pathophysiological basis, practical aspects, validity, reliability and its relative value (strengths and limitations) as compared to competitive modalities. Randomized controlled trials of acute myocardial infarction which have used CMR parameters as a primary endpoint are presented

Original languageEnglish
Article number204
JournalTrials
Volume12
DOIs
Publication statusPublished - 14.09.2011

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Dive into the research topics of 'Cardiac magnetic resonance imaging parameters as surrogate endpoints in clinical trials of acute myocardial infarction'. Together they form a unique fingerprint.

Cite this